We’ve solved many medical mysteries. Where are the cures? | Saloni Dattani

Medical progress is often hindered not by scientific limitations, but by economic incentives and institutional barriers. While breakthroughs in heart disease treatment and genome sequencing demonstrate human ingenuity, life-saving innovations frequently fail to reach those in need due to a lack of profitability in poorer markets. Addressing these systemic failures requires creative solutions like advanced market commitments, which guarantee funding for vaccines, and international research networks that accelerate clinical trials for rare conditions like childhood leukemia. By recognizing that diseases are solvable problems rather than inevitable facts of life, society can better align resources to ensure that medical advancements translate into widespread, equitable health outcomes. Persistent, collaborative efforts across scientific and economic sectors remain essential to overcoming the inertia that currently delays the deployment of critical, life-saving technologies.